Atlas Trials

COVID-19 Vaccine Messaging, Part 1

Clinical trial NCT04460703 · COMPLETED

Trial details

NCT number
NCT04460703
Sponsor
Yale University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
VaccinationCOVID-19
Start date
2020-07-03
Primary completion
2020-07-08
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.